Home Pharmaceutical europe-cold-sore-treatment-market

Pharmaceutical

Image

Europe Cold Sore Treatment Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Sep 2021
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 44

Europe Cold Sore Treatment Market – Industry Trends and Forecast to 2028

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2020–2028
Diagram Market Size (Base Year) USD 176.72 Million
Diagram Market Size (Forecast Year) USD 273.12 Million
Diagram CAGR %

Europe Cold Sore Treatment Market, By Strain Type (Herpes Simplex Type-1 Virus and Herpes Simplex Type-2 Virus), Therapeutics (Antiviral Agents, Analgesic Agents and Others), Drug Type (Branded and Generic), Dosage Type (Oral, Topical and Others), End User (Hospitals, Homecare, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others), Country (Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey and Rest of Europe) Industry Trends and Forecast to 2028.

Market Analysis and Insights: Europe Cold Sore Treatment Market

Cold sore treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.9% in the forecast period of 2021 to 2028 and is expected to reach USD 273.12 million by 2028 from USD 176.72 million in 2021.

Rising prevalence of Herpes simplex virus (HSV) globally and proliferation in modes of transmission of HSV are the major drivers which propelled the demand of the market in the forecast period.

Cold sores or oral herpes are small blisters like abrasions that occur due to the infection caused by the Herpes simplex virus (HSV). Cold sores generally occur on the face, around the lips, chin, cheeks, and nostrils. They generally cause pain, itching before they burst. HSV is one of the most common viruses found to affect the global population and it is endemic throughout the world. Up to 90% of people around the world have at least one form of HSV.

Herpes Simplex Virus (HSV) generally infects the pediatric population worldwide, but according to WHO, people aged 30-49 are at higher risk now for catching the virus, and the prevalence of HSV increases with age. HSV has two types: HSV type-1, and HSV type-2. HSV-1 causes cold sores or oral herpes around lips, nostrils, and cheeks. While HSV-2 cause’s genital herpes. HSV can be spread through the direct mode of transmission which includes oral contact inducing infection with oral herpes, from oral to skin surfaces that appear normal and when there is no symptoms present.

The cold sore treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Cold Sore Treatment Market Europe Cold Sore Treatment Market Scope and Market Size

The cold sore treatment market is categorized into six notable segments which are based on the strain type, therapeutics type, drug type, dosage type, end user and distribution channel.

  • On the basis of strain type, the cold sore treatment market is segmented into herpes simplex type-1 virus, and herpes simplex type-2 virus. In 2021, Herpes simplex type-1 virus (HSV), segment is dominating the market due to its rapidly increasing prevalence.
  • On the basis of therapeutics type, the cold sore treatment market is segmented into antiviral agents, analgesic agents, and others. In 2021, antiviral segment is expected to dominate the global cold sore treatment market due to the increased count of infectious diseases caused by herpes simplex virus and enhanced product pipeline in antiviral agents are predicted to dominate the market.
  • On the basis of drug type, the cold sore treatment market is segmented into branded and generics. In 2021, generics is dominating the global cold sore treatment market because it’s very less expensive as compared to branded drugs, and due to the economical nature, and increased usage for the treatment of cold sores globally.
  • On the basis of dosage type, the cold sore treatment market is segmented into oral, topical, and others. In 2021, oral segment is expected to dominate the global cold sore treatment market because of its ease of absorption and flexibility to accommodate various types of drugs.
  • On the basis of end user, the cold sore treatment market is segmented into hospitals, homecare, specialty clinics, and others. In 2021, homecare segment is dominating the market due to the ease in treatment at home and easy availability of drugs.
  • On the basis of distribution channel, the cold sore treatment market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. In 2021, hospital pharmacy is expected to dominate the market due to the rise in access to cold sore medications and surge in number of prescriptions of cold sore medications on a daily basis are predicted to dominate the market.

Europe Cold Sore Treatment Market Cold Sore Treatment Market Country Level Analysis

The cold sore treatment market is categorized into six notable segments which are based on the strain type, therapeutics type, drug type, dosage type, end user and distribution channel.

The countries covered in the cold sores treatment market report are Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey and Rest of Europe.

Germany in Europe is expected to grow with the most promising growth rate in the forecast period of 2021 to 2028 due to the increasing very rapidly due to rapidly increasing patient population and advancements in technology. France is expected to dominate due to rising awareness programs regarding sexually transmitted diseases acts as driver for the cold sore treatment market. However, the U.K. is expected to dominate due to increasing disposable income.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Strategic Initiatives by Manufactures is Creating New Opportunities for Players in the Cold Sore Treatment Market 

Cold sore treatment market also provides you with detailed market analysis for every country growth in aesthetic industry with Cold sore treatment sales, impact of advancement in the Cold sore treatment and changes in regulatory scenarios with their support for the Cold sore treatment market. The data is available for historic period 2010 to 2019.  

Competitive Landscape and Cold Sore Treatment Market Share Analysis

Cold sore treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Cold sore treatment market.

The major companies providing aesthetics  GlaxoSmithKline plc, Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Zydus Pharmaceuticals, Inc.(A Subsidiary of Zydus Cadila), Cipla Inc., AiCuris, Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.) , Aurobindo Pharma U.S.A.  (A Subsidiary of Aurobindo Pharma), WOCKHARDT, Novartis AG, Hikma Pharmaceuticals PLC, Hetero Healthcare Limited, Apotex Inc., HRA Pharma, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the cold sore treatment market.

  • In May 2020, Teva Pharmaceutical Industries Ltd. reported that the 2020 annual meeting of shareholders will be held online by looking at the COVID-19 scenario and in the interest of health and safety of its shareholders, directors, officers and employees. This will help in creating and discussing strategies for the coming year.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the cold sore treatment market which also provides the benefit for organisation to improve their offering for cold sore treatment.  

SKU-

TABLE 1 COLD SORE TREATMENT MARKET, PIPELINE ANALYSIS

TABLE 2 GENERIC DRUGS USED FOR THE TREATMENT OF HSV (COLD SORES)

TABLE 3 EUROPE COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 4 EUROPE COLD SORE TREATMENT MARKET, BY THERAPEUTICS 2019-2028 (USD MILLION)

TABLE 5 EUROPE ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 6 EUROPE ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 7 EUROPE COLD SORE TREATMENT MARKET, BY DRUG TYPE 2019-2028 (USD MILLION)

TABLE 8 EUROPE GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 9 EUROPE BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 10 EUROPE COLD SORE TREATMENT MARKET, BY DOSAGE TYPE 2019-2028 (USD MILLION)

ORAL SEGMENT IS SUB SEGMENTED INTO TABLETS AND PILLS. 79

TABLE 11 EUROPE ORAL SEGMENT IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 12 EUROPE TOPICAL SEGMENT IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 13 EUROPE COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 14 EUROPE COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 15 EUROPE COLD SORE MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 16 EUROPE COLD SORE MARKET, BY STRAIN, 2019-2028 (USD MILLION)

TABLE 17 EUROPE COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 18 EUROPE ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 19 EUROPE ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 20 EUROPE COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 21 EUROPE GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 22 EUROPE BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 23 EUROPE COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 24 EUROPE ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 25 EUROPE TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 26 EUROPE COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 27 EUROPE COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 28 GERMANY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 29 GERMANY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 30 GERMANY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 31 GERMANY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 32 GERMANY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 33 GERMANY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 34 GERMANY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 35 GERMANY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 36 GERMANY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 37 GERMANY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 38 GERMANY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 39 GERMANY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 40 FRANCE COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 41 FRANCE COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 42 FRANCE ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 43 FRANCE ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 44 FRANCE COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 45 FRANCE GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 46 FRANCE BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 47 FRANCE COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 48 FRANCE ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 49 FRANCE TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 50 FRANCE COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 51 FRANCE COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 52 U.K. COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 53 U.K. COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 54 U.K. ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 55 U.K. ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 56 U.K. COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 57 U.K. GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 58 U.K. BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 59 U.K. COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 60 U.K. ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 61 U.K. TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 62 U.K. COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 63 U.K. COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 64 ITALY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 65 ITALY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 66 ITALY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 67 ITALY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 68 ITALY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 69 ITALY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 70 ITALY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 71 ITALY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 72 ITALY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 73 ITALY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 74 ITALY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 75 ITALY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 76 SPAIN COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 77 SPAIN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 78 SPAIN ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 79 SPAIN ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 80 SPAIN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 81 SPAIN GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 82 SPAIN BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 83 SPAIN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 84 SPAIN ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 85 SPAIN TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 86 SPAIN COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 87 SPAIN COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 88 RUSSIA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 89 RUSSIA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 90 RUSSIA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 91 RUSSIA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 92 RUSSIA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 93 RUSSIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 94 RUSSIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 95 RUSSIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 96 RUSSIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 97 RUSSIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 98 RUSSIA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 99 RUSSIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 100 SWITZERLAND COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 101 SWITZERLAND COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 102 SWITZERLAND ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 103 SWITZERLAND ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 104 SWITZERLAND COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 105 SWITZERLAND GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 106 SWITZERLAND BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 107 SWITZERLAND COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 108 SWITZERLAND ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 109 SWITZERLAND TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 110 SWITZERLAND COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 111 SWITZERLAND COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 112 NETHERLAND COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 113 NETHERLAND COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 114 NETHERLAND ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 115 NETHERLAND ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 116 NETHERLAND COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 117 NETHERLAND GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 118 NETHERLAND BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 119 NETHERLAND COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 120 NETHERLAND ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 121 NETHERLAND TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 122 NETHERLAND COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 123 NETHERLAND COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 124 TURKEY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 125 TURKEY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 126 TURKEY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 127 TURKEY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 128 TURKEY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 129 TURKEY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 130 TURKEY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 131 TURKEY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 132 TURKEY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 133 TURKEY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 134 TURKEY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 135 TURKEY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 136 IRELAND COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 137 IRELAND COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 138 IRELAND ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 139 IRELAND ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 140 IRELAND COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 141 IRELAND GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 142 IRELAND BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 143 IRELAND COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 144 IRELAND ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 145 IRELAND TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 146 IRELAND COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 147 IRELAND COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 148 BELGIUM COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 149 BELGIUM COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 150 BELGIUM ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 151 BELGIUM ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 152 BELGIUM COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 153 BELGIUM GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 154 BELGIUM BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 155 BELGIUM COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 156 BELGIUM ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 157 BELGIUM TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 158 BELGIUM COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 159 BELGIUM COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 160 POLAND COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 161 POLAND COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 162 POLAND ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 163 POLAND ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 164 POLAND COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 165 POLAND GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 166 POLAND BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 167 POLAND COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 168 POLAND ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 169 POLAND TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 170 POLAND COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 171 POLAND COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 172 AUSTRIA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 173 AUSTRIA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 174 AUSTRIA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 175 AUSTRIA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 176 AUSTRIA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 177 AUSTRIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 178 AUSTRIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 179 AUSTRIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 180 AUSTRIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 181 AUSTRIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 182 AUSTRIA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 183 AUSTRIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 184 NORWAY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 185 NORWAY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 186 NORWAY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 187 NORWAY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 188 NORWAY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 189 NORWAY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 190 NORWAY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 191 NORWAY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 192 NORWAY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 193 NORWAY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 194 NORWAY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 195 NORWAY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 196 HUNGARY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 197 HUNGARY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 198 HUNGARY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 199 HUNGARY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 200 HUNGARY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 201 HUNGARY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 202 HUNGARY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 203 HUNGARY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 204 HUNGARY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 205 HUNGARY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 206 HUNGARY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 207 HUNGARY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 208 LITHUANIA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 209 LITHUANIA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 210 LITHUANIA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 211 LITHUANIA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 212 LITHUANIA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 213 LITHUANIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 214 LITHUANIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 215 LITHUANIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 216 LITHUANIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 217 LITHUANIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 218 LITHUANIA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 219 LITHUANIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 220 REST OF EUROPE COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

BROWSE RELATED REPORTS

Global Cold Sore Treatment Market – Industry Trends and Forecast to 2030
Asia-Pacific Cold Sore Treatment Market – Industry Trends and Forecast to 2028
Middle East and Africa Cold Sore Treatment Market – Industry Trends and Forecast to 2028
North America Cold Sore Treatment (for HSV 1 Virus) Market – Industry Trends and Forecast to 2030

BROWSE RELATED Blogs

Leading Players Shaping the Cold Sore Treatment Market: Innovations, Trends, and Market Dynamics Revealed
Europe Cold Sore Treatment Market is expected to grow at 5.9 % In the Forecast Period of 2021 to 2028
North America Cold Sore Treatment Market is Growing With 6.0% CAGR in the Forecast Period of 2021 To 2028

BROWSE RELATED Press Release

Innovative Breakthroughs Unveiled: New Approaches Transform Cold Sore Treatment, Easing Discomfort and Speeding Healing
GlaxoSmithKline plc, Novartis AG, and Hikma Pharmaceuticals PLC are dominating the Europe Cold Sore Treatment market in 2021
The Growing Prevalence of Cold Sore Infection Drives the Demand for the North America Cold Sore Treatment (for HSV 1 Virus) Market
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Can be used by entire organization across the globe + Downloadable and Printable PDF + 30 + Countries

Buy Now
Request for TOC Speak to Analyst Inquire Before Buying Free Sample Report
Advance Formative Research Customization Request for bulk Reports

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials

David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Image
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Image
Business Intelligence and Analytics,
Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst,
Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director,
Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO,
A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director,
Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager,
Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations,
GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst,
Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager,
Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment
MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer
Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro
Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future